Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Dose Escalating Study for Montbretin A

NCT05826054 is registered in ClinicalTrials.gov with Robert Petrella as lead sponsor.

NCT NCT05826054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05826054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Dose Escalating Study for Montbretin A
Lead sponsor
Robert Petrella
Phase
Phase 1
Overall status
Completed
Start date
December 1, 2023
Completion date
November 25, 2025
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes